Use of radiation in the treatment of age-related macular degeneration

Ophthalmology Clinics of North America

Volumn 15, Issue 4, 2002, Pages 437-444

  Flaxel, Christina J ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DOSE RESPONSE; HUMAN; INTERMETHOD COMPARISON; LOW ENERGY RADIATION; LOW LEVEL LASER THERAPY; PRIORITY JOURNAL; RADIATION DOSE; RADIATION INJURY; RETINA MACULA AGE RELATED DEGENERATION; RETINOPATHY; REVIEW; SUBRETINAL NEOVASCULARIZATION; TREATMENT PLANNING;

HUMANS; LASER COAGULATION; MACULAR DEGENERATION; PHOTOCHEMOTHERAPY;

EID: 0036956091     PISSN: 08961549     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0896-1549(02)00038-X     Document Type: Review

References (67)

1. American Academy of Ophthalmology. Age-Related Macular Degeneration: Preferred Practice Pattern. San Francisco: American Academy of Ophthalmology; 1998.
2. Ferris FL, Fine SL, Hyman L. Age-related macular degeneration and blindness due to neovascular maculopathy. Arch Ophthalmol 1984;102:1640-2.
3. Kahn HA, Leibowitz HM, Ganley JP, Kini MM, Colton T, Nickerson RS, et al. The Framingham Eye Study, II: Association of ophthalmic pathology with single variables previously measured in the Framingham heart study. Am J Epidemiol 1977;106:33-41.
4. Leibowitz HM, Krueger DE, Maunder LR, Milton RC, Kini MM, Kahn HA, et al. The Framingham Eye Study monograph: An ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol 1980;24(suppl):335-610.
5. Klein BE, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol 1982;100:571-3.
6. Vinding T. Age related macular degeneration, macular changes, prevalence and sex ratio. An epidemiological study of 1000 aged individuals. Acta Ophthalmol 1989;67:609-16.
7. Macular Photocoagulation Study group. Subfoveal neovascular lesions in AMD: Guidelines for evaluation and treatment in the Macular Photocoagulation Study. Arch Ophthalmol 1991;109:1242-57.
8. Macular Photocoagulation Study Group. Argon laser photocoagulation for AMD: Results of a randomized clinical trial. Arch Ophthalmol 1982;100:912-8.
9. Macular Photocoagulation Study Group. Krypton laser photocoagulation for neovascular lesions of AMD: Results of a randomized clinical trial. Arch Ophthalmol 1990;108:816-24.
10. Macular Photocoagulation Study Group. Recurrent CNV after argon laser treatment for neovascular maculopathy. Arch Ophthalmol 1986;104:503-12.
11. Macular Photocoagulation Study Group. Occult choroidal neovascularization: Influence on visual outcome in patients with age-related macular degeneration. Arch Ophthalmol 1996;114:400-12.
12. Macular Photocoagulation Study Group. Laser photocoagulation of subfoveal neovascular lesions in AMD: Results of a randomized clinical trial. Arch Ophthalmol 1991;109:1220-31.
13. Macular Photocoagulation Study Group. Visual outcome after laser photocoagulation for subfoveal CNV secondary to AMD: The influence of initial lesion size and initial visual acuity. Arch Ophthalmol 1994;112:480-8.
14. Moisseiev J, Alhalel A, Masuri R, Treister G. The impact of the Macular Photocoagulation Study results on the treatment of exudative age-related macular degeneration. Arch Ophthalmol 1995;113:185-9.
15. Freund KB, Yanuzzi LA, Sorenson JA. Age-related macular degeneration and choroidal neovascularization. Am J Ophthalmol 1993; 115:786-91.
16. Husain D, Miller JW, Michaud N, Connolly E, Flotte ES, Gragoudas ES. Intravenous infusion of liposomal benzoporphyrin derivative for photodynamic therapy of experimental choroidal neovascularization. Arch Ophthalmol 1996;114:978-85.
17. Kliman GH, Puliafito CA, Stem D, Borirakchanyavat S, Gregory WA. Phthalocyanine photodynamic therapy: New strategy for closure of choroidal neovascularization. Lasers Surg Med 1994; 15:2-10.
18. Lin SC, Lin CP, Feld JR, Duker JS, Puliafito CA. The photodynamic occlusion of choroidal vessels using benzoporphyrin derivative. Curr Eye Res 1994;13:513-22.
19. Miller JW, Walsh AW, Kramer M, Hasan T, Michaud N, Flotte TJ, et al. Photodynamic therapy of experimental choroidal neovascularization using lipopprotein-delivered benzoporphyrin. Arch Ophthalmol 1995;113:810-8.
20. Peyman GA, Moshfeghi DM, Moshfeghi A, Khoobehi B, Doiron DR, Primbs GB, et al. Photodynamic therapy for choroicapillaris using tin ethyl etiopurpurin (SnET2). Ophthalmic Surg Lasers 1997;28:409-17.
21. Schmidt-Erfurth U, Miller J, Sickenberg M, Bunse A, Laqua H, Gragoudas E, et al. Photodynamic therapy of subfoveal choroidal neovascularization: Clinical and angiographic examples. Graefes Arch Clin Exp Ophthalmol 1998;236:365-74.
22. Sickenberg M, Schmidt-Erfurth U, Miller JW, Bimgruber R, van den Bergh H, Strong HA, et al. A preliminary study of photodynamic therapy using verteporfin for choroidal neovascularization in pathologic myopia, ocula histoplasmosis syndrome, angioid streaks, and idiopathic causes. Arch Ophthalmol 2000; 118:327-36.
23. Treatment of age-related macular degeneration with photodynamic therapy (TAP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: One-year results of 2 randomized clinical trials - TAP report. Arch Ophthalmol 1999;117:1329-45.
24. Treatment of age-related macular degeneration with photodynamic therapy (TAP) study group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two-year results of 2 randomized clinical trials - TAP Report 2. Arch Ophthalmol 2001;119:198-207.
25. Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in age-related macular degeneration with verteporfin: Two year results of a randomized clinical trial including lesions with occult but not classic neovascularization - VIP Report 2. Am J Ophthalmol 2001;131:541-60.
26. Verteporfin in Photodynamic Therapy (VIP) Study Group. Photodynamic therapy of subfoveal choroidal neovascularization in pathologic myopia with verteporfin: One year results of a randomized clinical trial - VIP report 1. Ophthalmology 2001;108:841-52.
27. Verteporfin therapy: Clinical and practice applications update. Novartis Ophthalmics 2001.
28. Saperstein DA, Rosenfeld PJ, Rosa R, Sickenberg M. Verteporfin (Visudyne) based photodynamic therapy for subfoveal choroidal neovascularization [ARVO abstracts]. Invest Ophthalmol Vis Sci 2000;41:S176.
29. Finger PT, Augsberger JJ. Controversies, radiotherapy and the treatment of age-related macular degeneration. Arch Ophthalmol 1998;116:1507-11.
30. Baker DG, Krochak RJ. The response of the microvascular system to radiation: A review. Cancer Invest 1989;7:287-94.
31. Krishnan L, Krishnan EC, Jewell WR. Immediate effect of irradiation on microvasculature. J Radiat Oncol Biol Phys 1988;15:147-50.
32. Finger PT, Immonen I, Freire J, Brown G. Brachytherapy for macular degeneration associated with subretinal neovascularization. In: Alberti WE, Richard G, Sagerman RH, editors. Age-Related Macular Degeneration. Berlin: Springer-Verlag; 2001. p. 167-72.
33. Chakravarthy U, Gardiner TA, Archer DB, Maguire CJF. A light microscopic and autoradiographic study of non-irradiated and irradiated ocular wounds. Curr Eye Res 1989;8:337-48.
34. Archambeau JO, Mao XW, Yonemoto LT, Slater JD, Friedrichsen E, Teichman S, et al. What is the role of radiation in the treatment of subfoveal membranes: Review of radiobiologic, pathologic, and other considerations to initiate a multimodality discussion. Int J Radiat Oncol Biol Phys 1998;40:1125-36.
35. De Gowin RL, Lewis JL, Hoak JC, Mueller AL, Gibson DP. Radiosensitivity of human endothelial cells in culture. J Lab Clin Med 1974;84:42-8.
36. Hosoi Y, Yamamoto M, Ono T, Sakamoto K. Prostacyclin production in cultured endothelial cells is highly sensitive to low doses of ionizing radiation. Int J Radiat Biol 1993;63:631-8.
37. Finger PT. Radiation therapy for choroidal melanoma. Surv Ophthalmol 1997;42:215-32.
38. Johnson LK, Longenecker JP, Fajardo LF. Differential radiation response of cultured endothelial cells and smooth myocytes. Anal Quant Cytol 1982;4:188-98.
39. Sagerman RH, Chung CT, Alberti WE. Radiosensitivity of ocular and orbital structures. In: Alberti WE, Sagerman RH, editors. Radiotherapy of Intraocular and Orbital Tumors. Berlin: Springer-Verlag; 1993. p. 375-86.
40. Langley RE, Bune EA, Quartuccio SG, Medeiras D, Braunhut SJ. Radiation induced apoptosis in microvascular endothelial cells. Br J Cancer 1997;75:666-72.
41. Finger PT, Chankravarthy Y. External beam radiation therapy is effective in the treatment of age-related macular degeneration. Arch Ophthalmol 1998;116: 1507-9.
42. Engenhart R, Wowra B, Debus J, Kimmig BN, Hover KH, Lorenz W, et al. The role of high-dose, singlefraction irradiation in small and large intracranial arteriovenous malformations. Int J Radiat Oncol Biol Phys 1994;30:521-9.
43. nd Edition. Philadelphia: JB Lippincott; 1992.
44. Plowman PN, Hamett AN. Radiotherapy in benign orbital disease, I: Complicated ocular angiomas. Br J Ophthalmol 1988;72:286-8.
45. Schilling H, Sauerwein W, Lommatzsch A, Friedrichs W, Brylak S, Bomfeld N, et al. Long-term results after low dose ocular irradiation for choroidal haemamgiomas. Br J Ophthalmol 1997;81:267-73.
46. Scott TA, Augsburger JJ, Brady LW, Hernandez C, Woodleigh R. Low dose ocular irradiation for diffuse choroidal hemangiomas assoicated with bullous nonrhegmatogenous retinal detachment. Retina 1991;11: 389-93.
47. Mainster MA, Reichel E. Transpupillary thermotherapy for age-related macular degeneration: Long-pulse photocoagulation, apoptosis and heat-shock proteins. Ophthalmic Surg Lasers 2000;31:359-73.
48. Brown GC, Shields JA, Sanbom G, Augsburger JJ, Savino PJ, Schatz NJ. Radiation retinopathy. Ophthalmology 1982;89:1494-501.
49. Chan RC, Shukovsky LJ. Effects of irradiation on the eye. Radiology 1976;120:673-5.
50. Parsons JT, Fitzgerald CR, Hood CI, Ellingwood KE, Bova FJ, Million RR. The effects of irradiation on the eye and optic nerve. Int J Radiat Oncol Biol Phys 1983;9:609-22.
51. Archer DB, Amoaku SMK, Gardinier TA. Radiation retinopathy, clinical, histological and ultrastructural correlations. Eye 1991;5:239-51.
52. Chakravarthy U, Houston RF, Acher DB. Treatment of age-related subfoveal neovascular membranes by teletherapy: A pilot study. Br J Ophthalmol 1993;77: 265-73.
53. Study Protocol. Radiotherapy in the Management of Subfoveal Choroidal Neovascular Membranes of Age-Related Macular Degeneration. Southampton and London, Belfast: 1995.
54. Finger PT, Berson A, Sherr D, Riley R, Balkin RA, Bosworth JL. Radiation therapy for subretinal neovascularization. Ophthalmology 1996;103:878-89.
55. Stalmans P, Leys A, Van Limbergen E. External beam radiation therapy (20 Gy, 2 Gy fractions) fails to control the growth of choroidal neovascularization in agerelated macular degeneration: A review of 1 1 1 cases. Retina 1997;17:481-92.
56. Spaide RF, Guyer DR, McCormick B, Yanuzzi LA, Burke K, Mendelsohn M, et al. External beam radiation therapy for choroidal neovascularization. Ophthalmology 1998;105:24-30.
57. Donati G, Soubrane D, Quaranta M, Coscas G, Soubrane G. Radiotherapy for isolated occult subfoveal neovascularisation in age-related macular degeneration: A pilot study. Br J Ophthalmol 1999;83:646-51.
58. Mauget-Faysse M, Chiquet C, Milea D, Romestaing P, Gerard JP, Martin P, et al. Long term results of radiotherapy for subfoveal choroidal neovascularisation in age related macular degeneration. Br J Ophthalmol 1999;83:923-8.
59. Finger PT, Berson A, Ng T, Szechter A. Ophthalmic plaque radiotherapy for age-related macular degeneration associated with subretinal neovascularization. Am J Ophthalmol 1999;127:170-7.
60. Bergink GJ, Deutman AF, van den Broek JFCM, van Daal WA, van der Maazen RW. Radiation therapy for age-related subfoveal choroidal neovascular membranes: A pilot study. Doc Ophthalmol 1995;90:67-74.
61. Bergink GJ, Hoyng CB, van der Maazen RWM. A randomized controlled trial on efficacy of radiation therapy in the control of subfoveal choroidal neovascularization in age-related macular degeneration: Radiation versus observation. Graefes Arch Clin Exp Ophthalmol 1998;236:321-5.
62. Flaxel CJ, Friedrichsen EJ, Smith JO, Oeinck SC, Blacharski PA, Garcia CA, et al. Proton beam irradiation of subfoveal choroidal neovascularization in age-related macular degeneration. Eye 2000;14:155-64.
63. The Radiation Therapy for Age-related Macular Degeneration (RAD) Study Group. A prospective, randomized, double-masked trial on radiation therapy for neovascular age-related macular degeneration (RAD Study). Ophthalmology 1999;106:2239-47.
64. Kobayashi H, Kobayashi K. Age-related macular degeneration: Long-term results of radiotherapy for subfoveal neovascular membranes. Am J Ophthalmol 2000;130:617-35.
65. Marcus DM, Sheils C, Johnson MH, McIntosh SB, Leibach DB, Maguire A, et al. External beam irradiation of subfoveal choroidal neovascularization complicating age-related macular degeneration: One-year results of a prospective, double-masked randomized clinical trial. Arch Ophthalmol 2001;119:171-80.
66. Chakravarthy U, Hart PM, Mackenzie G, Bird AC, Owens SL, Chisholm IH, et al. External beam radiotherapy for subfoveal choroidal neovascularization: Visual outcomes in a multicenter randomized controlled trial [ARVO abstracts]. Invest Ophthalmol Vis Sci 2001;42:S127.
67. Study Protocol. The Age-Related Macular Degeneration and Radiation Trial (AMDRT): United States. 1999.